Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

Clinical trial NCT03610438 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03610438
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoid Leukemia

Start date: 2019-10-30
Primary completion: 2026-07-15
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.